Log In
Sign Up
Find a Lawyer
Ask a Lawyer
Research the Law
Law Schools
Laws & Regs
Newsletters
Marketing Solutions
Justia Connect
Pro Membership
Practice Membership
Public Membership
Justia Lawyer Directory
Platinum Placements
Gold Placements
Justia Elevate
SEO
Websites
Blogs
Justia Amplify
PPC Management
Google Business Profile
Social Media
Justia Onward Blog
Justia
Patents
Patents Assigned to Sanofi-Aventis Biotechnology
Patents Assigned to Sanofi-Aventis Biotechnology
Methods for treating digitally identified IL-4/IL-13-related disorders by administering an anti-IL4R-alpha antibody
Patent number:
11723974
Abstract:
Disclosed are methods of treating various disorders with anti-IL-4R? antibodies and fragments thereof.
Type:
Grant
Filed:
December 8, 2020
Date of Patent:
August 15, 2023
Assignee:
Sanofi-Aventis Biotechnology
Inventors:
Paul Bryce, Emanuele De Rinaldis, Ramon Antonio Hernandez Vecino, Francisco Javier Jimenez Jimenez, Cliona Marie Molony